![leadership-new.jpg](https://images.squarespace-cdn.com/content/v1/5f77665fce2a6e2e65763cf0/1607196184452-RJ8VKHGZGSK4DCXSBSHA/leadership-new.jpg)
We are a patient-focused, collaborative and passionate team of trailblazers, innovators, and creative thinkers dedicated to realizing the potential of microglia biology and delivering life-changing therapeutics to patients, caregivers and families
MANAGEMENT
OUR TEAM
![white-background-lighter.jpg](https://images.squarespace-cdn.com/content/v1/5f77665fce2a6e2e65763cf0/1606100217314-CBHB7RL7V6C2TUFHC8KS/white-background-lighter.jpg)
BOARD OF DIRECTORS
![dark-blue-background.jpg](https://images.squarespace-cdn.com/content/v1/5f77665fce2a6e2e65763cf0/1605184189571-ODMR3VGLP5QT6BHV0RTG/dark-blue-background.jpg)
SCIENTIFIC ADVISORY BOARD
Chairman - Marco Colonna, MD
Robert Rock Belliveau Professor of Pathology & Immunology, Washington University
John Dunlop, PhD
Chief Scientific Officer, Aliada Therapeutics
Jaime Grutzendler, MD
Dr. Harry M. Zimmerman and Dr. Nicholas and Viola Spinelli Professor of Neurology and Neuroscience; Vice-Chair for Research, Neurology; Director, Center for Experimental Neuroimaging, Yale School of Medicine
Bradley Hyman, MD, PhD
John B. Penney, Jr. Professor of Neurology, Harvard Medical School; Alzheimer’s Unit Director, MassGeneral Institute for Neurodegenerative Disease; Director, Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital
Ole Isacson, MD, PhD
Professor Neurology & Neuroscience Harvard Medical School, Massachusetts General Hospital, McLean Hospital, HSCI
![blue-background.jpg](https://images.squarespace-cdn.com/content/v1/5f77665fce2a6e2e65763cf0/1606163687425-AM98QBAD2O17GWRB5RP6/blue-background.jpg)